Literature DB >> 33460771

Effect of the ammonium salt anion on the structure of doxorubicin complex and PEGylated liposomal doxorubicin nanodrugs.

Yaelle Schilt1, Tal Berman2, Xiaohui Wei2, Einat Nativ-Roth3, Yechezkel Barenholz4, Uri Raviv5.   

Abstract

BACKGROUND: In Doxil®, PEGylated nanoliposomes are created by hydration of the lipids in ammonium sulfate, and are remotely loaded with doxorubicin by a transmembrane ammonium gradient. The ammonium sulfate is then removed from the external aqueous phase, surrounding the liposomes, and replaced by an isoosmotic sucrose solution in 10 mM histidine buffer at pH 6.5.
METHODS: We prepared PEGylated liposomal doxorubicin (PLD) with a series of ammonium monovalent salts that after remote loading became the intraliposome doxorubicin counteranions. We analyzed the liposomes by solution X-ray scattering, differential scanning calorimetry, and electron micropscopy.
RESULTS: PLDs prepared with sulfonic acid derivatives as counteranion exhibited chemical and physical stabilities. We determined the effect of these ammonium salt counteranions on the structure, morphology, and thermotropic behavior of the PEGylated nanoliposomes, formed before and after doxorubicin loading, and the bulk properties of the doxorubicin-counteranion complexes. By comparing the structure of the doxorubicin complexes in the bulk and inside the nanoliposomes, we revealed the effect of confinement on the structure and doxorubicin release rate for each of the derivatives of the ammonium sulfonic acid counteranions.
CONCLUSIONS: We found that the extent and direction of the doxorubicin confinement effect and its release rate were strongly dependent on the type of counteranion. The counteranions, however, neither affected the structure and thermotropic behavior of the liposome membrane, nor the thickness and density of the liposome PEG layers. In an additional study, it was demonstrated that PLD made with ammonium-methane sulfonate exhibit a much lower Hand and Foot syndrome. GENERAL SIGNIFICANCE: The structure, physical state, and pharmacokinetics of doxorubicin in PEGylated nanoliposomes, prepared by transmembrane remote loading using gradients of ammonium salts, strongly depend on the counteranions.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Confinement; PEGylated liposomal doxorubicin; Palmar-plantar Erythrodysesthesia; SAXS; WAXS

Mesh:

Substances:

Year:  2021        PMID: 33460771     DOI: 10.1016/j.bbagen.2021.129849

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  5 in total

1.  Moxifloxacin Liposomes: Effect of Liposome Preparation Method on Physicochemical Properties and Antimicrobial Activity against Staphylococcus epidermidis.

Authors:  Evangelos Natsaridis; Foteini Gkartziou; Spyridon Mourtas; Marc C A Stuart; Fevronia Kolonitsiou; Pavlos Klepetsanis; Iris Spiliopoulou; Sophia G Antimisiaris
Journal:  Pharmaceutics       Date:  2022-02-07       Impact factor: 6.321

Review 2.  Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer.

Authors:  Xin-Ru Li; Xing-Han Cheng; Guo-Nan Zhang; Xiao-Xin Wang; Jian-Ming Huang
Journal:  J Ovarian Res       Date:  2022-08-16       Impact factor: 5.506

3.  A Novel Diosgenin-Based Liposome Delivery System Combined with Doxorubicin for Liver Cancer Therapy.

Authors:  Lixia Chen; Jinshuai Lan; Zhe Li; Ruifeng Zeng; Yu Wang; Lu Zhen; Haojieyin Jin; Yue Ding; Tong Zhang
Journal:  Pharmaceutics       Date:  2022-08-12       Impact factor: 6.525

Review 4.  Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and Pharmacodynamic Properties.

Authors:  Giuseppina Ioele; Martina Chieffallo; Maria Antonietta Occhiuzzi; Michele De Luca; Antonio Garofalo; Gaetano Ragno; Fedora Grande
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

5.  PEGylated Liposomes Remotely Loaded with the Combination of Doxorubicin, Quinine, and Indocyanine Green Enable Successful Treatment of Multidrug-Resistant Tumors.

Authors:  Emma Grabarnick Portnoy; Alexander V Andriyanov; Hadas Han; Sara Eyal; Yechezkel Barenholz
Journal:  Pharmaceutics       Date:  2021-12-17       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.